trending Market Intelligence /marketintelligence/en/news-insights/trending/a3xkhj0MeWqbNtVJiP6VOQ2 content esgSubNav
In This List

Lupin launches generic female contraceptive in US

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Lupin launches generic female contraceptive in US

Lupin Ltd. launched a generic version of Janssen Pharmaceuticals Inc.'s female contraceptive tablet Ortho-Cyclen.

The norgestimate and ethinyl estradiol tablets are approved by the U.S. FDA. Ortho-Cyclen generated $204 million in U.S. sales during the 12 months ended September 2016, according to IMS Health data.

Janssen Pharmaceuticals is a Johnson & Johnson unit.